Request Sample Inquiry
Dystrophin Market

Dystrophin Market

Dystrophin Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

168

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1251

Segments Covered
  • By Product By Product Exondys51, Translarna, Emflaza, Others
  • By Approach By Approach Exon Skipping, Anti-Inflammatory Therapy, Stop Codon Read-Through, Others Approaches
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.46 Billion
Revenue 2030Revenue 2030: USD 29.53 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 45.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Dystrophin Market - Segment Analysis
    1. Overview
    2. Global Dystrophin Market, 2016 - 2028 (USD Million)
    3. Global Dystrophin Market - by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. Global Dystrophin Market - by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. Global Dystrophin Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Dystrophin Market - Segment Analysis
    1. Overview
    2. North America Dystrophin Market, 2016 - 2028 (USD Million)
    3. North America Dystrophin Market, by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. North America Dystrophin Market, by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. North America Dystrophin Market, by Country
      1. U.S.
        1. U.S. Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. U.S. Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      2. Canada
        1. Canada Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Canada Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      3. Mexico
        1. Mexico Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Mexico Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
  5. Europe Dystrophin Market - Segment Analysis
    1. Overview
    2. Europe Dystrophin Market, 2016 - 2028 (USD Million)
    3. Europe Dystrophin Market, by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. Europe Dystrophin Market, by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. Europe Dystrophin Market, by Country
      1. Germany
        1. Germany Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Germany Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      2. UK
        1. UK Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. UK Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      3. France
        1. France Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. France Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      4. Spain
        1. Spain Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Spain Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      5. Italy
        1. Italy Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Italy Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      6. BENELUX
        1. BENELUX Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. BENELUX Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      7. Rest of Europe
        1. Rest Of Europe Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Rest Of Europe Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
  6. Asia Pacific Dystrophin Market - Segment Analysis
    1. Overview
    2. Asia Pacific Dystrophin Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Dystrophin Market, by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. Asia Pacific Dystrophin Market, by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. Asia Pacific Dystrophin Market, by Country
      1. China
        1. China Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. China Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      2. Japan
        1. Japan Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Japan Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      3. India
        1. India Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. India Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      4. South Korea
        1. South Korea Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. South Korea Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      5. South East Asia
        1. South East Asia Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. South East Asia Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Rest of Asia Pacific Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
  7. Latin America Dystrophin Market - Segment Analysis
    1. Overview
    2. Latin America Dystrophin Market, 2016 - 2028 (USD Million)
    3. Latin America Dystrophin Market, by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. Latin America Dystrophin Market, by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. Latin America Dystrophin Market, by Country
      1. Brazil
        1. Brazil Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Brazil Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      2. Argentina
        1. Argentina Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Argentina Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      3. Rest of Latin America
        1. Rest of Latin America Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Rest of Latin America Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
  8. Middle East & Africa Dystrophin Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Dystrophin Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Dystrophin Market, by Product
      1. By Exondys51
      2. By Translarna
      3. By Emflaza
      4. By Others
    4. Middle East & Africa Dystrophin Market, by Approach
      1. By Exon Skipping
      2. By Anti-Inflammatory Therapy
      3. By Stop Codon Read-Through
      4. By Others Approaches
    5. Middle East & Africa Dystrophin Market, by Country
      1. GCC Countries
        1. GCC Countries Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. GCC Countries Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      2. South Africa
        1. South Africa Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. South Africa Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Dystrophin Market, By Product
          1. By Exondys51
          2. By Translarna
          3. By Emflaza
          4. By Others
        2. Rest of Middle East & Africa Dystrophin Market, By Approach
          1. By Exon Skipping
          2. By Anti-Inflammatory Therapy
          3. By Stop Codon Read-Through
          4. By Others Approaches
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. PTC Therapeutics
    2. Sarepta Therapeutics
    3. BioMarin Pharmaceutical Inc
    4. Wave Life Sciences
    5. Bristol-Myers Squibb and Catabasis
    6. Pharmaceuticals among others.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 30-Jan-2022
Dystrophin Market to Reach USD USD 30.22 Billion Billion by 2028
FAQ
Frequently Asked Question

  • The global Dystrophin valued at USD 1.46 Billion in 2022 and is expected to reach USD 29.53 Billion in 2030 growing at a CAGR of 45.60%.

  • The prominent players in the market are PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis, Pharmaceuticals among others..

  • The market is project to grow at a CAGR of 45.60% between 2023 and 2030.

  • The driving factors of the Dystrophin include

    • Emergence of Mutation-Specific Therapies, Rising Incidence of the Condition, and Improved Diagnostics

  • North America was the leading regional segment of the Dystrophin in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy